Dr. Lafayette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 650-725-6186Fax+1 650-725-8418
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Nephrology, 1988 - 1991
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1985 - 1987
- New York Medical CollegeClass of 1985
Certifications & Licensure
- CA State Medical License 1988 - 2025
- MA State Medical License 1992 - 1996
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Start of enrollment: 2005 Jun 01
- Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy Start of enrollment: 2009 Feb 01
- MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsPrecision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.Laura H Mariani, Sean Eddy, Fadhl M AlAkwaa, Phillip J McCown, Jennifer L Harder
Kidney International. 2023-03-01 - 77 citationsDevelopment and evaluation of deep learning-based segmentation of histologic structures in the kidney cortex with multiple histologic stains.Catherine P. Jayapandian, Yijiang Chen, Andrew Janowczyk, Matthew B. Palmer, Clarissa A. Cassol
Kidney International. 2021-01-01 - 12 citationsComparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis.Debbie S Gipson, Jonathan P Troost, Cathie Spino, Samara Attalla, Joshua Tarnoff
JAMA Network Open. 2022-08-01
Journal Articles
- Cause of Kidney Disease and Cardiovascular Events in a National Cohort of US Patients with End-Stage Renal Disease on Dialysis: A Retrospective AnalysisWolfgang C Winkelmayer, Richard A Lafayette, European Heart Journal
Abstracts/Posters
- Facing the Vexing Problem of Recurrent FSGS After Kidney TransplantationRichard Lafayette, MD, American Society of Nephrology, Orlando, FL, 12/7/2019
- Facing the Vexing Problem of Recurrent FSGS After Kidney TransplantationRichard Lafayette, MD, American Society of Nephrology, Orlando, FL, 12/7/2019
Press Mentions
- Calliditas Announces Late-Breaking Presentations at the 60th European Renal Association (ERA) Congress 2023May 5th, 2023
- Omeros Announces Results from Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy TrialNovember 5th, 2021
- Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA NephropathySeptember 9th, 2021
- Join now to see all
Grant Support
- Oral Calcimimetic Agent In Secondary HyperparathyroidismNational Center For Research Resources2000–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: